Presented by: GEORGE SCORSIS CEO

Similar documents
THE STATE OF THE STATES-A REPORT ON MEDICAL CANNABIS PROGRAMS MID YEAR MEETING AND SCIENTIFIC SEMINAR APRIL 13, 2018 NASHVILLE, TENNESSEE DEBBY MIRAN

AN ECONOMIC IMPACT REPORT (EIR) ON THE MEDICAL CANNABIS INDUSTRY IN THE STATE OF NEVADA

States with Authority to Require Nonresident Pharmacies to Report to PMP

2012 Medicaid and Partnership Chart

THE STATE OF THE MEDICAL MARIJUANA MARKETS 2011

Marijuana in the Workplace: The 411 on 420

MICHIGAN MEDICAL MARIJUANA REGULATION: From Home Remedy to Criminalization. to State Regulated Industry. March 22, Stephen K.

Responses to a 2017 Survey on State Policies Regarding Community Health Workers: Home Visiting to Improve the Home Environment

Using Policy, Programs, and Partnerships to Stamp Out Breast and Cervical Cancers

Medical Marijuana: Is Green & Leafy Really Good for You? Objectives 2/14/2015. Do you live in a state where medical Marijuana is legal?

Research Protocol for Medical Marijuana Dispensaries. Prepared by Legal Science, LLC

In New York State. Highly Worth It OR Not??? Medical Marijuana. The Truths 3/29/2018. True or False???

ADVERTISING - CALIFORNIA

2018 HPV Legislative Report Card

MAKING WAVES WITH STATE WATER POLICIES. Washington State Department of Health

Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory. Definitions Obesity: Body Mass Index (BMI) of 30 or higher.

Community Meeting: Local Cannabis Policy in Oroville

EDIBLE CANNABIS STATE REGULATIONS. Karmen Hanson, MA- Health Program

Medical Marijuana and Student Health. New England College Health Association Gordon H. Smith, Esq. October 30, 2014

Nevada s Marijuana Roots

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

The State of Cannabis in Oregon

ACEP National H1N1 Preparedness Survey Results

HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview

Investment in MGC Pharmaceuticals

ADVANCE FOR PHYSICAL THERAPY AND REHAB MEDICINE

Youth and Adult Marijuana Use

E N H A N C IN G HE A LTH THRO U GH CANNABIS S CIENCE

Colorado s Cannabis Experience Doug Friednash

SECOND EDITION STATE OF THE EMERGING MARIJUANA INDUSTRY CURRENT TRENDS AND PROJECTIONS

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

The Verde Mountain Fund offers a unique opportunity to gain early entry into one of the fastest growing industries in a generation.

Overview of the States Pesticide Registration Process AAPCO Laboratory Committee

Percent of U.S. State Populations Covered by 100% Smokefree Air Laws April 1, 2018

Instant Drug Testing State Law Guide

Pennsylvania s Medical Marijuana Act. William Roark, Esq. HRMM&L

Autism and Transition to Adulthood. Lorri Unumb, Esq. Vice President State Government Affairs Autism Speaks

Public Health Federal Funding Request to Address the Opioid Epidemic

Medical Marijuana Responsible for Traffic Fatalities Alfred Crancer, B.S., M.A.; Phillip Drum, Pharm.D.

SECOND EDITION STATE OF THE EMERGING MARIJUANA INDUSTRY CURRENT TRENDS AND PROJECTIONS EXECUTIVE SUMMARY

Investor Presentation

Medical Marijuana Update

Diane E. Hoffmann, J.D., M.S. University of Maryland School of Law

Opioid Deaths Quadruple Since 1999

Obesity Trends:

HIV in Prisons,

Legal Licensing and Compliance in the Commercial Cannabis Industry

Work Session VIII: Legalized Marijuana. Douglas J. Friednash City Attorney Denver, Colorado

Hawai i to Zero. Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health. January 16, 2018

Merced, California Next Steps and Strategies for Successful Implementation of Cannabis-Related Health and Safety Regulations

BDS ANALYTICS Top Ten Cannabis Market Trends for 2019

Georgina Peacock, MD, MPH

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

MARIJUANA IN THE PUBLIC WORKPLACE PHILIP A. TOOMEY

National Deaf Center on Postsecondary Outcomes. Data Interpretation Guide for State Reports: FAQ

The Wellbeing of America s Workforce, and Its Effects on an Organization s Performance

North Central Florida Regional Planning Council

SUMMARY OF SYNTHETIC CANNABINOID BILLS

Smoke and Mirrors: Navigating Medical Marijuana in the Workplace

Marijuana Legalization Update

Canadian Marijuana Industry Snapshot: 17 Charts

Analysis of State Medicaid Agency Performance in Relation to Incentivizing the Provision of H1N1 Immunizations to Eligible Populations

which has been used to help the treatment of epilepsy, seizures, alleviate neuropathic pain and muscular dystrophy.

THE STEPPING UP INITIATIVE

2011 Jackson Lewis LLP. Prop 203 Passes by Thread

CONTROL, REGULATION, AND TAXATION OF MARIJUANA AND INDUSTRIAL HEMP ACT PRESENTATION TO LEGISLATIVE TASK FORCE ON OLCC 11/19/14

AMERICAN ROOTS. GLOBAL REACH CSE: TGIF FWB: 1QF OTC: TGIFF

AUL s 2014 Life List

Health Care Reform: Colorectal Cancer Screening Expansion, Before and After the Affordable Care Act (ACA)

STATE RANKINGS REPORT NOVEMBER mississippi tobacco data

Compassionate Medical Cannabis: What It Means to the Street Officer

Prop 203 Passes by Thread

MetLife Foundation Alzheimer's Survey: What America Thinks

Medical Marijuana Compliance. Neil Alexander and Sarah Watt Littler Mendelson P.C. May 9, 2017

STATE ALZHEIMER S DISEASE PLANS: WORKFORCE DEVELOPMENT

INVESTOR PRESENTATION

The Healthy Indiana Plan

Proposition 64 Adult Use Marijuana Act (AUMA) with Information on Medical Cannabis

Cannabis in Indian Country. Lael Echo-Hawk, Attorney

Trip Report February 26, 2019

Canopy Growth Corporation

Autism Activities at CDC: The Public Health Model

April 25, Edward Donnell Ivy, MD, MPH

Maine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014

Regulating Commercial Cannabis Activity within the City of Los Angeles: An Update on Cannabis Policy Development and Implementation

Forensic Patients in State Hospitals:

Medical Cannabis Comes to Maryland: What Finance Professionals Need to Know About this Budding Industry

Medical Advisory Board. reviews medical issues for licensure regarding individual drivers. medical conditions. not specified. reporting encouraged,

I. Why planning & public health Mass in Motion approach: healthy community design III. Bringing public health & planning together in Worcester IV.

Average Number Citations per Recertification Survey

Medical Marijuana Legalization and the Impact on Colorado s Counties. CCAP Workshop

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017

Navigating Marijuana Law in the Workplace

CDC activities with Autism Spectrum Disorders

Recommendations for Re-Occupancy of Buildings Previously Used to Manufacture Methamphetamine

Shannon Whitman Program Administrator Advancing Use of the MN PMP

Sodium Reduction Strategies: State-level Opportunities. Jill Birnbaum Vice President, State Advocacy & Public Health

The 2004 National Child Count of Children and Youth who are Deaf-Blind

ARIZONA MEDICAL MARIJUANA PROGRAM. Tina Wesoloskie, MPA Office of Medical Marijuana Card Registry Arizona Department of Health Services

Transcription:

Presented by: GEORGE SCORSIS CEO CSE: LHS OTCBB: LHSIF

Who We Are Liberty is one of twelve licensed producers and sellers of medical cannabis in Florida. Liberty prioritizes investment in states that meet the following criteria: 2% MEDICAL STATES HIGHLY REGULATED NO CANOPY RESTRICTIONS 2% STATES

Who We Are OUR EXPERTISE: OUR COMMITMENT: Industry leading greenhouse operators Thorough knowledge of regulated industries Strong management team To become the low-cost producer, utilizing Aphria s innovative greenhouse methods and technology To produce pharmaceutical grade cannabis of the highest standard To continuously improve and innovate our offerings with our science-based approach

At A Glance INNOVATION Lumigrow Resolve GROWING OPERATIONS Alachua County, FL: 36 acres 56,000 sq. ft. (2018) Ohio: 136 acres 125,000 sq ft INVESTMENT 38% Aphria PRODUCTS Global Aphria brand Mary s partnership Lifestyle brand in production (development of edibles, topicals, vape products RETAIL 4 dispensaries (17 by 2018) OPERATION Aphria knowhow system Seed-to-Sale Program SCIENCE University of Ohio cannabis research project

Our Team MANAGEMENT: George Scorsis CEO & Director 20+ Years in CPG working with regulated products Former President of Mettrum Health Corp building it to a $430M business Former President of Red Bull Canada Former Executive Leader at Bacardi Canada Rene Gulliver CFO 30+ years of senior financial management experience with public company CFO experience CPA,CA certified Capital markets experience, raising in excess of $500M over the years Extensive international M&A experience BOARD: Vic Neufeld CEO, Aphria 20+ Years in Pharma Former CEO of Jamieson Laboratories (1993 2014) Demonstrated vision, growth & performance John Cervini Co-Founder & VP Infrastructure & Technology, Aphria 20+ Years in Agri-business Fourth generation greenhouse grower Proven growth & expansion track record Aaron Serruya CEO, YogenFrüz Leader in franchises, co-founder and CEO of YogenFrüz Winner of numerous awards for business excellence Will lead the dispensary expansion initiative in Florida and other states where investments are made

Future of Legal Cannabis US MEDICAL MARKET POTENTIAL BY 2020 $7.3B $18.9B >$18.9B Total Market Size Potential Information based on Deloitte Recreational Marijuana POV Analysis on Canadians in 2016

Future of Legal Cannabis NORTH AMERICAN LEGAL CANNABIS SPENDING 2015-2021 In Billions 970M 1.8B 2.5B 4.2B 7.6B 10.7B 14.9B 4.0B 4.9B 5.68B 7.0B 7.0B 7.3B 7.7B

US Adoption of Legal Cannabis Recreational use allowed Medicinal use allowed Illegal Decriminalized

Regulatory Framework TIMELINE OF STATE MARIJUANA LAWS 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 California Alaska Orego n Washingto n Main e Colorado Hawaii Nevada Montana Vermont Rhode Island 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 New Mexico Michigan Recreational (8 states & D.C.) Delaware Illinois Arizon New Hampshire anew Jersey Connecticut Washington, D.C. Massachusett s Colorado Washington Medical (29 states & D.C.) Maryland Minnesot a New York Alaska Oregon Washington, D.C. West Virginia Arkansas Florida North Dakota Ohio Pennsylvania California Maine Massachuset tsnevada

Regulatory Framework Federal US law states that cannabis is a Schedule I drug (having a high potential for abuse and has no accepted medical use in treatment) which is at odds with the laws that have been passed in 29 states authorizing a medical use. of the US population reside where medical 60%cannabis is legal 20% of Americans now live where adult-use cannabis is legal 93% of Americans support legalizing doctorprescribed medical marijuana according to a recent poll

Regulatory Framework Leahy Appropriations Amendment: Amendment that will continue to prevent the use of federal funds to prosecute medical cannabis providers in approved States. Amendment will be finalized Dec. 8, 2017. MEDS ACT: Encourage more research on the potential medical uses of marijuana by streamlining the research registration process Compassionate Access Act: provide for the rescheduling of cannabis, the medical use of cannabis in accordance with State law, and the exclusion of cannabidiol from the definition of cannabis on schedule 1, and for other purposes. Small Business Tax Equity Act of 2017: This Act will would allow statelegal cannabis businesses to take normal business deductions like any other legal business. Known as 280E, the tax code provision prevents cannabis businesses from taking normal business deductions related to sales Veterans Equal Access Act: This Act would allow physicians and medical workers at the U.S. Department of Veterans Affairs to recommend medical cannabis for military veterans.

Timeline NOV 2017: OHIO Approval of Ohio License Application MAR 2018: FLORIDA Phase I of Florida expansion to be complete 4 additional dispensarie s to open FEB 2019: OHIO Phase II of Florida expansion to be complete JULY 2017: FLORIDA Acquisition of Chestnut Hill Tree Farm in Alachua County DEC 2017: FLORIDA 4 dispensaries to be opened in Florida SEPT 2018: OHIO Product ready to be sold in Ohio

Florida Market OVERVIEW Population: 20,600,000 Market: $1.6bn by 2020 Qualifying Patients: 6,065,927 (30%) Registered Patients: 36,400 (up 200%+ over last 3 mos.) Ordering Physicians: 1,043 (up 27% in 8 weeks) No. of Licenses: 12 Dispensaries: 25 dispensaries / license (only 16 locations currently statewide) Legal Product Scope: Cannabis Oil and Edibles (1) The State of Legal Marijuana Markets, 5 th Ed, published by Arcview Market Research in partnership with BDS Analytics, *Potential Rec Market in 2021 (2) https://mjbizdaily.com/florida-lawmakers-reach-agreement-medical-marijuana-rules/; https://www.greenroadsworld.com/pages/cbd-oil-in-florida (3) CDC, Arthritis Foundation, Aidsview, Hepview, Prevent Blindness America, American Academy of Neurology, National Centre for PTSD (4) There are 12 licenses currently issued. (5) There are 26 other conditions outlined in the Florida MMJ regulations

Florida Market DIVERSE PATIENT BASE Canada has approximately 800k people per license in comparison to Florida which has 1.7 MM people per license. By 2020, Florida is projected to have a larger medical marijuana market than Colorado ($1.6bn vs. $1.5bn) (1) The State of Legal Marijuana Markets, 5 th Ed, published by Arcview Market Research in partnership with BDS Analytics, *Potential Rec Market in 2021 (2) https://mjbizdaily.com/florida-lawmakers-reach-agreement-medical-marijuana-rules/; https://www.greenroadsworld.com/pages/cbd-oil-in-florida (3) CDC, Arthritis Foundation, Aidsview, Hepview, Prevent Blindness America, American Academy of Neurology, National Centre for PTSD (4) There are 12 licenses currently issued. (5) There are 26 other conditions outlined in the Florida MMJ regulations

Future Plans for Florida Liberty s growth in Florida will come through our expansion in three critical areas: Capacity Dispensaries Patient Count

Capacity Prod. Capacity: 3,000kg annually Facility: 56,000 sq.ft. July 2017 March 2018 February 2019 Prod. Capacity: 700kg annually Facility: 14,000 sq.ft. Prod. Capacity: 13,000kg annually Facility: 187,000 sq.ft.

Leveraging two-pronged sales strategy Unique cost structure enables Liberty Health Sciences to capitalize on wholesale advantages. RETAIL Completely vertical market with up to 25 dispensaries being opened Increasing patient sales Highly profitable (~ 70% margin with 30% costs below the line) WHOLESALE Sale of bulk product to other Licensed Producers ~70-75% margin

Patient Count Growth Driven by: 1.Leaders in Professional and Medical Outreach 2.Increased Accessibility due to Dispensaries 3.Increased Capacity grams sold Phase 2: 56,000 sq. ft. Phase 3: 187,000 sq. ft. Patients Phase 1: 14,000 sq. ft.

Dispensaries Pensacola Geographic Target Criteria: General Population Number of Prescribing Doctors Number of Adult Lifestyle Communities Veteran Population Tallahassee Jacksonville The Villages Orlando Tampa October 2017: Villages December 2017: Fort Lauderdale, Miami, Tampa June 2018: Orlando, Tallahassee, Jacksonville, Pensacola Fort Lauderdale Miami

Dispensaries

CEC

Timeline OCT 2017: OHIO Approval of Ohio License Application MAR 2018: FLORIDA Phase I of Florida expansion to be complete 4 additional dispensarie s to open FEB 2019: OHIO Phase II of Florida expansion to be complete JULY 2017: FLORIDA Acquisition of Chestnut Hill Tree Farm in Alachua County DEC 2017: FLORIDA 4 dispensaries to be opened in Florida SEPT 2018: OHIO Product ready to be sold in Ohio

Ohio THE MARKET Population: 11,600,000 Licenses: 24 cultivators - 12 level 1 (large producers), 12 level 2 (craft producers), 40 processors, 40 dispensaries Estimated current users: 870,000 (7.5%) (number includes recreational users) People with qualifying conditions: 2,804,359 (24%)

Ohio Liberty Health Sciences has partnered with the prominent Schottenstein Family on this application (51%) The Schottenstein family has been prominent in Ohio for decades and have long led some of America's largest fashion retailers: SPG Group is recognized as one of the largest privately held portfolios of premier retail properties in the country with holdings in more than 156 properties across 27 states.

In Conclusion FLORIDA OHIO Population: 20,600,000 Qualifying Patients: 6,065,985 (30%) No. of Licenses: 12 Population: 11,600,000 Qualifying Patients: 2,804,359 (24%) No. of Licenses: 12 TOTAL MARKET SIZE Population: 32,200,000 Qualifying Patients: 8,870,344

THANK YOU